GSK's RAPT Therapeutics acquisition will strengthen the former's immunology pipeline – specifically its offerings for food ...

Regene Therapeutics has received RMAT designation from the US FDA for its lead product, NouvNeu001, aimed at treating PD.

Pfizer exits ViiV Healthcare with a $1.89bn payout, while GSK retains its majority stake amid the shareholder shake-up.

DeepHow has launched PharmaCloud, a GMP-compliant cloud environment developed specifically to standardise AI-driven operator ...

Dermatology in the near future will be characterized by digitally enabled, patient-centred research that reaches people where ...

The key element of the agreement is confirmation that UK pharmaceutical exports to the US will face a preferential tariff ...

Novartis has announced that the FDA has granted a breakthrough therapy designation to ianalumab, a treatment for Sjögren’s ...

Strive Compounding Pharmacy alleges the two pharma companies are coordinating an effort to restrict compounded access.

AstraZeneca has agreed to buy AbelZeta’s 50% stake in the China development and commercialisation rights for C-CAR031.

The arrival of oral Wegovy across 70,000 US pharmacies offers a more affordable and convenient weight-loss treatment option ...

Immunocore is expanding its ImmTAX platform into autoimmune disease, outlining plans to start first‑in‑human trials of ...

Despite a lacklustre FDI environment in British life sciences, the pharma industry could be set for a period of renaissance amid US trade agreements.